Cordlife Group (SG:P8A) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cordlife Group Limited has been instructed by the Ministry of Health to limit its cord blood banking services to 30 units per month until January 2025, which is expected to negatively impact the company’s financials for the year. Shareholders and potential investors are advised to seek professional advice when dealing with the company’s shares amid these operational constraints. The company will keep the market informed of any significant changes as per Singapore Exchange listing rules.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
